Yangsan

The trials here

What the 6 trials at this site are about, from their registry records.

Conditions

• Familial hypercholesterolaemia2 trials
• ALS (motor neurone disease)1 trial
• Asthma1 trial
• Heart failure1 trial
• Macular degeneration1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting3 trials
• Completed2 trials
• Recruiting1 trial

Lead sponsor

• Novartis Pharmaceuticals6 trials

Running trials

• Recruiting

  Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)

  NCT06770543· Novartis Pharmaceuticals· Source

  Contact: Novartis Pharmaceuticals

• Active, not recruiting

  A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)

  NCT06643481· Phase 2· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A 24-week rPMS Study in Real-world Setting for Enerzair

  NCT05274425· Novartis Pharmaceuticals· Source

• Active, not recruiting

  Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease

  NCT05030428· Phase 3· Novartis Pharmaceuticals· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Familial hypercholesterolaemia1 recruiting

Closed trials

• Completed

  Regulatory Post-Marketing Surveillance Study for Brolucizumab

  NCT04985487· Novartis Pharmaceuticals· Source

• Completed

  Open-label Extension Study to Evaluate Long-term Safety of Sacubitril/Valsartan in Pediatric Patients With HF

  NCT03785405· Phase 3· Novartis Pharmaceuticals· Source